Corrigan Financial, Inc. Abb Vie Inc. Transaction History

Corrigan Financial, Inc.

$436 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 01, 2023	BUY	$132.51 - $164.9 $265 - $329	2 Added 0.07%	2,680 $361 Million
Q1 2023 Sep 01, 2023	SELL	$144.61 - $166.54 $17,931 - $20,650	-124 Reduced 4.43%	2,678 $427 Million
Q4 2022 Sep 01, 2023	BUY	$138.31 - $165.87 $414 - $497	3 Added 0.11%	2,802 $453 Million
Q3 2022 Sep 01, 2023	BUY	$134.21 - $153.93 $536 - $615	4 Added 0.14%	2,799 $376 Million
Q2 2022 Sep 01, 2023	SELL	$137.62 - $174.96 $137,344 - $174,610	-998 Reduced 26.31%	2,795 $428 Million
Q1 2022 Sep 01, 2023	BUY	$131.98 - $163.75 $124,193 - $154,088	941 Added 32.99%	3,793 $615 Million
Q4 2021 Sep 01, 2023	SELL	$107.43 - $135.93 $19,767 - $25,011	-184 Reduced 6.06%	2,852 $386 Million
Q2 2021 Sep 01, 2023	SELL	$105.21 - $117.21 $18,411 - $20,511	-175 Reduced 5.45%	3,036 $342 Million
Q1 2021 Sep 01, 2023	BUY	$102.3 - $112.62 $204 - $225	2 Added 0.06%	3,211 $348 Million
Q4 2020 Sep 01, 2023	BUY	$80.49 - $108.67 $160 - $217	2 Added 0.06%	3,209 $344 Million
Q3 2020 Sep 01, 2023	SELL	$85.91 - $100.83 $72,851 - $85,503	-848 Reduced 20.91%	3,207 $281 Million
Q2 2020 Sep 01, 2023	BUY	$73.37 - $98.18 $146 - $196	2 Added 0.05%	4,055 $398 Million
Q1 2020 Sep 01, 2023	SELL	$64.5 - $97.79 $64 - $97	-1 Reduced 0.02%	4,053 $309 Million
Q4 2019 Sep 01, 2023	BUY	$72.13 - $90.25 $360 - $451	5 Added 0.12%	4,054 $359 Million
Q3 2019 Sep 01, 2023	BUY	$62.98 - $75.72 $188 - $227	3 Added 0.07%	4,049 $307 Million
Q2 2019 Sep 01, 2023	SELL	$65.7 - $83.98 $39,288 - $50,220	-598 Reduced 12.88%	4,046 $294 Million
Q1 2019 Aug 31, 2023	BUY	$77.14 - $90.79 $123,424 - $145,264	1,600 Added 52.56%	4,644 $374 Million
Q4 2018 Aug 31, 2023	BUY	$77.85 - $96.01 $155 - $192	2 Added 0.07%	3,044 $281 Million
Q3 2018 Aug 31, 2023	SELL	$88.91 - $98.84 $34,674 - $38,547	-390 Reduced 11.36%	3,042 $288 Million
Q2 2018 Aug 31, 2023	BUY	$89.78 - $106.23 $179 - $212	2 Added 0.06%	3,432 $318 Million
Q1 2018 Aug 31, 2023	BUY	$92.01 - $123.21 $23,094 - $30,925	251 Added 7.9%	3,430 $325 Million
Q4 2017 Aug 31, 2023	SELL	$89.56 - $98.21 $1,970 - $2,160	-22 Reduced 0.69%	3,179 $307 Million
Q3 2017 Aug 31, 2023	SELL	$69.85 - $89.22 $10,267 - $13,115	-147 Reduced 4.39%	3,201 $284 Million
Q2 2017 Aug 31, 2023	BUY	N/A	3,348	3,348 $243 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.

Account